Kenvue’s stock (KVUE) is down over 13% from its year-to-date high after the CEO was ousted and a strategic review was announced. Interim CEO Kirk Perry has deep experience in consumer goods and data-driven transformation, signaling a proactive reset for the company. Analysts see potential for a 27% increase in stock price to $27, with a 3.74% dividend yield as an added incentive to buy. Wall Street firms recommend buying KVUE shares at current levels, with a consensus rating of “Moderate Buy” and a mean target price of $24.50, indicating over 12% potential upside.

Read more at Yahoo Finance: Tylenol-Maker Kenvue Launches Turnaround Plans. How Should You Play KVUE Stock Here?